Late-phase cutaneous reactions to platelet activating factor and kallikrein in urticaria.
Juhlin
L
L
Department of Dermatology, University Hospital, Uppsala, Sweden.
D000328:Adult; D017332:Cetirizine; D002908:Chronic Disease; D005260:Female; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006801:Humans; D006919:Hydroxyzine / Q000031:analogs & derivatives / Q000494:pharmacology; D006968:Hypersensitivity, Delayed / Q000276:immunology*; D007271:Injections, Intradermal; D007610:Kallikreins / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D010972:Platelet Activating Factor / Q000494:pharmacology*; D012867:Skin / Q000276:immunology*; D014581:Urticaria / Q000276:immunology*
D006634:Histamine H1 Antagonists; D010972:Platelet Activating Factor; D006919:Hydroxyzine; D007610:Kallikreins; D017332:Cetirizine